Literature DB >> 4178712

Human serum inhibitor of C'1 esterase: identity with alpha-2-neuraminoglycoprotein.

J Pensky, H G Schwick.   

Abstract

A comparison of highly purified C'1 esterase inhibitor from human serum and alpha(2)-neuraminoglycoprotein from human plasma by immunofusion, immuneelectrophoresis, and discgel electrophoresis showed them to be antigenically identical.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4178712     DOI： 10.1126/science.163.3868.698

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  18 in total

1.  Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.

Authors:  M H Prandini; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

2.  Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Authors:  B L Zuraw; J G Curd
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.

Authors:  P K Ray; R L Simmons
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

4.  Complement in respiratory immunopathology.

Authors:  C Molina; J Brun; D Wahl
Journal:  Lung       Date:  1979       Impact factor: 2.584

5.  Two complement inhibitors in mouse sera.

Authors:  H D Adolphs
Journal:  Med Microbiol Immunol       Date:  1973-03-08       Impact factor: 3.402

6.  The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.

Authors:  P K Ray; H Gewurz; R L Simmons
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

7.  Hereditary angio-oedema.

Authors:  F W Webb; E G Bywaters
Journal:  Proc R Soc Med       Date:  1970-03

Review 8.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

9.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

10.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.